Topics
October 2016 | Cover Focus: New Developments
5-Year Results With a Retinal Prosthesis System
Patients with severe to profound RP are experiencing promising outcomes with the Argus II.
Lyndon da Cruz, MA, MD, PhD
May 15, 2026
AI Reshapes Retinal Disease Research, International Study Finds
May 14, 2026
Topcon Expands ARVO Presence with Record Research Activity
May 13, 2026
NeuroVision Acquires Durin Life Sciences to Expand Neurodegenerative Disease Diagnostics Platform
Study: Popular GLP-1 Drugs Linked to Certain Optic Nerve Disorders
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar
